HLB bioStep Co.,Ltd. (KOSDAQ:278650)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,463.00
-11.00 (-0.75%)
Last updated: Jul 16, 2025

HLB bioStep Company Description

HLB bioStep Co.,Ltd. provides various test services.

It offers platform technology services, such as cell-enzyme-based screening, xenograft assay, mitogenic effect test, vaccine antigen, antibody titration, cytokine, MRNA expression, trachea relaxation assay, carrageenan, adjuvant induced paw edema, antipyretic, anti-pain test, isolated blood vessel screening, fibrin plate lysis screening, ferric chloride induced model, food diet induced model, gastric acid secretion, emesis model, MIC test, post antibody effect, enzyme assay, systemic, local infection model, PK study, chemical, transgenic animal, osteoblast-like cell line screening, bone formation marker, and biomarker.

The company also provides pharmacokinetic/toxico study, toxicology study, and biological drug; and toxic/clinical pathology services.

The company was formerly known as KNOTUS Co.,Ltd. The company was founded in 2012 and is based in Incheon, South Korea.

HLB bioStep Co.,Ltd.
CountrySouth Korea
Founded2012
IndustryCommercial Physical and Biological Research
Employees150

Contact Details

Address:
38 Academy-ro
Incheon, 22014
South Korea
Phone82 32 833 8899
Websitehlbbiostep.com

Stock Details

Ticker Symbol278650
ExchangeKOSDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyKRW
SIC Code8731